These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 34169426

  • 1. Diagnostic and Prognostic Significance of Keap1 mRNA Expression for Lung Cancer Based on Microarray and Clinical Information from Oncomine Database.
    Liu GY, Zhang W, Chen XC, Wu WJ, Wan SQ.
    Curr Med Sci; 2021 Jun; 41(3):597-609. PubMed ID: 34169426
    [Abstract] [Full Text] [Related]

  • 2. Integrated analysis of patients with KEAP1/NFE2L2/CUL3 mutations in lung adenocarcinomas.
    Jin X, Zheng Y, Chen Z, Wang F, Bi G, Li M, Liang J, Sui Q, Bian Y, Hu Z, Qiao Y, Xu S.
    Cancer Med; 2021 Dec; 10(23):8673-8692. PubMed ID: 34617407
    [Abstract] [Full Text] [Related]

  • 3. The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC.
    Fu L, Wang H, Wei D, Wang B, Zhang C, Zhu T, Ma Z, Li Z, Wu Y, Yu G.
    PLoS One; 2020 Dec; 15(5):e0233283. PubMed ID: 32437446
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
    Namani A, Matiur Rahaman M, Chen M, Tang X.
    BMC Cancer; 2018 Jan 06; 18(1):46. PubMed ID: 29306329
    [Abstract] [Full Text] [Related]

  • 7. Unveiling ficolins: diagnostic and prognostic biomarkers linked to the Tumor Microenvironment in Lung Cancer.
    Zhang Z, Geng X, Yin M, Zhang S, Liu Y, Hu D, Zheng G.
    World J Surg Oncol; 2024 Oct 10; 22(1):273. PubMed ID: 39390580
    [Abstract] [Full Text] [Related]

  • 8. A potential therapeutic strategy based on acute oxidative stress induction for wild-type NRF2/KEAP1 lung squamous cell carcinoma.
    Sánchez-Ortega M, Garrido A, Cirauqui C, Sanz-Gonzalez L, Hernández MC, González-García A, Obregon K, Ferrer I, Paz-Ares L, Carrera AC.
    Redox Biol; 2024 Sep 10; 75():103305. PubMed ID: 39137583
    [Abstract] [Full Text] [Related]

  • 9. A comparative analysis indicates SLC7A11 expression regulate the prognostic value of KEAP1-NFE2L2-CUL3 mutations in human uterine corpus endometrial carcinoma.
    Namani A, Veeraiyan D, Patra T.
    Free Radic Biol Med; 2024 Sep 10; 222():223-228. PubMed ID: 38876457
    [Abstract] [Full Text] [Related]

  • 10. The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma.
    Chen A, Ding S, Shen X, Lin X.
    Comput Math Methods Med; 2021 Sep 10; 2021():9932088. PubMed ID: 34367321
    [Abstract] [Full Text] [Related]

  • 11. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in KRAS-Mutant Lung Adenocarcinoma.
    Galan-Cobo A, Sitthideatphaiboon P, Qu X, Poteete A, Pisegna MA, Tong P, Chen PH, Boroughs LK, Rodriguez MLM, Zhang W, Parlati F, Wang J, Gandhi V, Skoulidis F, DeBerardinis RJ, Minna JD, Heymach JV.
    Cancer Res; 2019 Jul 01; 79(13):3251-3267. PubMed ID: 31040157
    [Abstract] [Full Text] [Related]

  • 12. System analysis of FHIT in LUAD and LUSC: The expression, prognosis, gene regulation network, and regulation targets.
    Situ Y, Gao R, Lei L, Deng L, Xu Q, Shao Z.
    Int J Biol Markers; 2022 Jun 01; 37(2):158-169. PubMed ID: 35254116
    [Abstract] [Full Text] [Related]

  • 13. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
    Li Y, Sun N, Lu Z, Sun S, Huang J, Chen Z, He J.
    Cancer Lett; 2017 May 01; 393():40-51. PubMed ID: 28223168
    [Abstract] [Full Text] [Related]

  • 14. Clinicopathological, microenvironmental and genetic determinants of molecular subtypes in KEAP1/NRF2-mutant lung cancer.
    Cai MC, Chen M, Ma P, Wu J, Lu H, Zhang S, Liu J, Zhao X, Zhuang G, Yu Z, Fu Y.
    Int J Cancer; 2019 Feb 15; 144(4):788-801. PubMed ID: 30411339
    [Abstract] [Full Text] [Related]

  • 15. NFE2L2/KEAP1 Mutations Correlate with Higher Tumor Mutational Burden Value/PD-L1 Expression and Potentiate Improved Clinical Outcome with Immunotherapy.
    Xu X, Yang Y, Liu X, Cao N, Zhang P, Zhao S, Chen D, Li L, He Y, Dong X, Wang K, Lin H, Mao N, Liu L.
    Oncologist; 2020 Jun 15; 25(6):e955-e963. PubMed ID: 32272498
    [Abstract] [Full Text] [Related]

  • 16. PLEK2 Gene Upregulation Might Independently Predict Shorter Progression-Free Survival in Lung Adenocarcinoma.
    Zhang W, Li T, Hu B, Li H.
    Technol Cancer Res Treat; 2020 Jun 15; 19():1533033820957030. PubMed ID: 33084541
    [Abstract] [Full Text] [Related]

  • 17. The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.
    Tian WJ, Liu SS, Li BR.
    Technol Cancer Res Treat; 2020 Jun 15; 19():1533033820977504. PubMed ID: 33256552
    [Abstract] [Full Text] [Related]

  • 18. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
    Yao Y, Zhang T, Qi L, Liu R, Liu G, Wang J, Song Q, Sun C.
    Biosci Rep; 2020 Jan 31; 40(1):. PubMed ID: 31950990
    [Abstract] [Full Text] [Related]

  • 19. NOP16 promotes hepatocellular carcinoma progression and triggers EMT through the Keap1-Nrf2 signaling pathway.
    Mu S, Tian Q, Shen L.
    Technol Health Care; 2024 Jan 31; 32(4):2463-2483. PubMed ID: 38251077
    [Abstract] [Full Text] [Related]

  • 20. Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance.
    Jeong Y, Hoang NT, Lovejoy A, Stehr H, Newman AM, Gentles AJ, Kong W, Truong D, Martin S, Chaudhuri A, Heiser D, Zhou L, Say C, Carter JN, Hiniker SM, Loo BW, West RB, Beachy P, Alizadeh AA, Diehn M.
    Cancer Discov; 2017 Jan 31; 7(1):86-101. PubMed ID: 27663899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.